AU3117600A - Composition and method for regulation of body weight and associated conditions - Google Patents

Composition and method for regulation of body weight and associated conditions

Info

Publication number
AU3117600A
AU3117600A AU31176/00A AU3117600A AU3117600A AU 3117600 A AU3117600 A AU 3117600A AU 31176/00 A AU31176/00 A AU 31176/00A AU 3117600 A AU3117600 A AU 3117600A AU 3117600 A AU3117600 A AU 3117600A
Authority
AU
Australia
Prior art keywords
regulation
composition
body weight
associated conditions
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31176/00A
Other languages
English (en)
Inventor
Miles B. Brennan
Ute Hochgeschwender
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roosevelt Eleanor Institute for Cancer Research Inc
Oklahoma Medical Research Foundation
Original Assignee
Roosevelt Eleanor Institute for Cancer Research Inc
Oklahoma Medical Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/374,827 external-priority patent/US6603058B1/en
Application filed by Roosevelt Eleanor Institute for Cancer Research Inc, Oklahoma Medical Research Foundation filed Critical Roosevelt Eleanor Institute for Cancer Research Inc
Publication of AU3117600A publication Critical patent/AU3117600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU31176/00A 1998-12-09 1999-12-09 Composition and method for regulation of body weight and associated conditions Abandoned AU3117600A (en)

Applications Claiming Priority (21)

Application Number Priority Date Filing Date Title
US11158198P 1998-12-09 1998-12-09
US60111581 1998-12-09
US14630499P 1999-07-29 1999-07-29
US14630699P 1999-07-29 1999-07-29
US14630599P 1999-07-29 1999-07-29
US14630099P 1999-07-29 1999-07-29
US14630199P 1999-07-29 1999-07-29
US14630399P 1999-07-29 1999-07-29
US14629999P 1999-07-29 1999-07-29
US14630299P 1999-07-29 1999-07-29
US60146301 1999-07-29
US60146303 1999-07-29
US60146304 1999-07-29
US60146299 1999-07-29
US60146300 1999-07-29
US60146306 1999-07-29
US60146302 1999-07-29
US60146305 1999-07-29
US09/374,827 US6603058B1 (en) 1998-12-09 1999-08-12 Non-human animal model for obesity and uses thereof
US09374827 1999-08-12
PCT/US1999/029337 WO2000033658A1 (en) 1998-12-09 1999-12-09 Composition and method for regulation of body weight and associated conditions

Publications (1)

Publication Number Publication Date
AU3117600A true AU3117600A (en) 2000-06-26

Family

ID=27581011

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31176/00A Abandoned AU3117600A (en) 1998-12-09 1999-12-09 Composition and method for regulation of body weight and associated conditions

Country Status (6)

Country Link
EP (1) EP1137340A4 (es)
JP (1) JP2003520015A (es)
AU (1) AU3117600A (es)
CA (1) CA2353776A1 (es)
MX (1) MXPA01005818A (es)
WO (1) WO2000033658A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406755A1 (en) * 2000-04-28 2001-11-08 Zengen Inc. A gene therapy system and method using alpha-msh and its derivatives
EP1303625A2 (en) 2000-07-14 2003-04-23 Zycos Inc. Alpha-msh related compounds and methods of use
EP1322954A4 (en) * 2000-09-13 2005-08-03 Eleanor Roosevelt Inst METHOD FOR TREATING INSULIN RESISTANCE IN OVERWEIGHT AND DIABETES
AU2002238106A1 (en) 2001-02-13 2002-08-28 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
JP2006527773A (ja) * 2003-06-19 2006-12-07 イーライ リリー アンド カンパニー メラノコルチン受容体４（ｍｃ４）作用薬とその用途
US20060293223A1 (en) * 2003-06-19 2006-12-28 Eli Lilly And Company Patent Division Uses of melanocortin-3 receptor (mc3r) agonist peptides
FR2857873B1 (fr) * 2003-07-21 2006-02-24 Courtage Et De Diffusion Codif Procede et produit cosmetique destines a limiter la croissance des tissus adipeux
EP1732586A1 (en) * 2004-03-29 2006-12-20 Eli Lilly And Company Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continunous infusion
BRPI0508787A (pt) * 2004-04-08 2007-09-04 Astellas Pharma Inc composto ws727713, cepa de actinomiceto, composto com atividade moduladora de receptor de melanocortina, processo para produzir o composto ws727713, modulador de receptor de melanocortina, uso do composto e composição farmacêutica
WO2005118573A1 (en) 2004-05-28 2005-12-15 Smithkline Beecham Corporation Novel diazepine compounds as ligands of the melanocortin 1 and/or 4 receptors
US7169773B2 (en) 2004-07-01 2007-01-30 Smithkline Beecham Corporation Compounds
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
PL1812046T3 (pl) * 2004-10-25 2011-08-31 Centocor Ortho Biotech Inc Przeciwciała naśladowcze wiążące receptor melanokortyny, kompozycje, sposoby i zastosowania
WO2006073771A2 (en) * 2005-01-05 2006-07-13 Eli Lilly And Company Polyethylene glycol linked mc4r or mc3r agonist peptides
US7790671B2 (en) 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
AU2009248914A1 (en) 2008-05-21 2009-11-26 Neurotez, Inc. Methods for Treating Neurodegenerative Disorders Related to Neurofibrillary Tangles
CA2742600A1 (en) 2008-11-04 2010-05-14 Nikolaos Tezapsidis Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100048A (en) * 1992-04-10 2000-08-08 Oregon Health Sciences University Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
US5932779A (en) * 1996-06-10 1999-08-03 Millennium Pharmaceuticals, Inc. Screening methods for compounds useful in the regulation of body weight

Also Published As

Publication number Publication date
EP1137340A1 (en) 2001-10-04
JP2003520015A (ja) 2003-07-02
CA2353776A1 (en) 2000-06-15
EP1137340A4 (en) 2005-12-21
MXPA01005818A (es) 2003-07-21
WO2000033658A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
AU5802499A (en) Diet composition and method of weight management
ZA989875B (en) Composition and method for inhibiting the growth of microorganisms including stabilized sodium hypbromite and isothiazolones
AU3117600A (en) Composition and method for regulation of body weight and associated conditions
ZA9711421B (en) Method and compositions for weight control
AU1289899A (en) Methods and compositions for regulation of 5-alpha reductase activity
AU2757097A (en) Method of coating and compositions for use therein
AU2593900A (en) Composition and method for treating glaucoma
AU2747497A (en) Compositions and methods for antisense inhibition of protein translation
AU7264298A (en) Apparatus and method for the reduction of snoring
AU3475099A (en) Composition for tissue welding and method of use
AU5979496A (en) Composition and methods for losing weight
AU3497295A (en) Compositions and methods for the treatment of body weight disorders, including obesity
AU5080199A (en) Diltiazem controlled release formulation and method of manufacture
AU9016898A (en) Methods and compositions for treatment of restenosis
AU6469196A (en) Use of basic aminoacids and derivatives for lowering ceramide levels
AU7755398A (en) Method for reducing body weight
AU3065999A (en) Compositions and methods for treatment of asthma
AU1564000A (en) Method and equipment for controlling properties of paper
AU4636199A (en) Method of reducing or preventing malodour
AU1723001A (en) Methods and means for regulation of gene expression
AUPP010397A0 (en) Method and composition for treatment of sexual dysfunction
AU7717894A (en) Method and composition for weight reduction
HUP9801629A3 (en) Methods and compositions for regulation of cd28 expression
AU4525299A (en) Method of reducing or preventing malodour
AU3044199A (en) Mastic composition and method of preparing same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase